Candel Therapeutics (CADL) Research & Development: 2020-2023
Historic Research & Development for Candel Therapeutics (CADL) over the last 4 years, with Dec 2023 value amounting to $7.3 million.
- Candel Therapeutics' Research & Development rose 45.98% to $7.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $24.5 million, marking a year-over-year increase of 17.89%. This contributed to the annual value of $19.3 million for FY2024, which is 21.19% down from last year.
- Latest data reveals that Candel Therapeutics reported Research & Development of $7.3 million as of Q4 2023, which was up 24.17% from $5.8 million recorded in Q3 2023.
- In the past 5 years, Candel Therapeutics' Research & Development ranged from a high of $7.3 million in Q4 2023 and a low of $1.6 million during Q2 2020.
- Over the past 3 years, Candel Therapeutics' median Research & Development value was $5.3 million (recorded in 2021), while the average stood at $5.0 million.
- Data for Candel Therapeutics' Research & Development shows a peak YoY soared of 190.40% (in 2021) over the last 5 years.
- Quarterly analysis of 4 years shows Candel Therapeutics' Research & Development stood at $3.5 million in 2020, then increased by 9.05% to $3.9 million in 2021, then rose by 29.01% to $5.0 million in 2022, then surged by 45.98% to $7.3 million in 2023.
- Its Research & Development was $7.3 million in Q4 2023, compared to $5.8 million in Q3 2023 and $5.9 million in Q2 2023.